Malignant Rectal Neoplasm — Trials

Malignant Rectal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,551 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 388
Recruiting: 216
Ph III recruiting: 36
Growth YoY: +12%
Industry share: 5%
Top sponsor: Fudan University
Termination share: 28%
Trials / 1,000 deaths: 30.1 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (153)

clinicaltrialsPublishedShowing 151–155 of 155 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00137878	TNFerade™ Plus Chemo/Radiation/Surgery for Rectal Cancer	completed	Phase 2	—	GenVecINDUSTRY	1	Feb 23, 2012	clinicaltrials
NCT00297128	Preoperative Chemoradiation With Capecitabine and Cetuximab	completed	Phase 2	31	Austrian Breast & Colorectal Cancer Study GroupNETWORK	1	Dec 30, 2011	clinicaltrials
NCT00422864